Advertisement

Pathology of Advanced Gastric Cardiac Carcinoma Cancer

  • Qin Huang
Chapter

Abstract

Once invading the muscularis propria and beyond, gastric cardiac carcinoma becomes much more aggressive with extensive locoregional invasion and distant metastasis. Unlike distal esophageal Barrett’s adenocarcinoma with pure tubular/papillary growth patterns, advanced gastric cardiac carcinoma demonstrates a much broader histopathologic spectrum with a substantial proportion of cases showing uncommon histologic types and rare entities, which is also more common than gastric non-cardiac carcinoma, suggesting different pathogenesis mechanisms.

Keywords

Stomach Cancer Gastric cancer Gastroesophageal carcinoma Carcinoma with lymphoid stroma Poorly cohesive carcinoma Adenosquamous carcinoma 

References

  1. 1.
    Huang Q, Fan XS, Agoston AT, et al. Comparison of gastroesophageal junction carcinomas in Chinese versus American patients. Histopathology. 2011;59:188–97.CrossRefPubMedGoogle Scholar
  2. 2.
    Huang Q, Zhang LH. The histopathologic spectrum of carcinomas involving the gastroesophageal junction in the Chinese. Int J Surg Pathol. 2007;15(1):38–52.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Wang HH, Antonioli DA, Goldman H. Comparative features of esophageal and gastric adenocarcinomas: recent changes in type and frequency. Hum Pathol. 1986;17:482–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Smith RR, Hamilton SR, Boitnott JK, et al. The spectrum of carcinoma arising in Barrett’s esophagus. A clinicopathologic study of 26 patients. Am J Surg Pathol. 1984;8:563–73.CrossRefPubMedGoogle Scholar
  5. 5.
    Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett’s esophagus. Gastroenterology. 1995;109(5):1541–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Ekström AM, Signorello LB, Hansson LE, et al. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst. 1999;91:786–90.CrossRefPubMedGoogle Scholar
  7. 7.
    Chandrasoma P, Makarewicz K, Wickramasinghe K, et al. A proposal for a new validated histological definition of the gastroesophageal junction. Hum Pathol. 2006;37:40–7.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Chandrasoma P, Wickramasinghe K, Ma Y, et al. Adenocarcinomas of the distal oesophagus and “gastric cardia” are predominantly esophageal carcinomas. Am J Surg Pathol. 2007;31:569–75.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    American Joint Committee on Cancer Staging Manual. Chapter 10: Esophagus and esophagogastric junction. In: AJCC cancer staging manual. 7th ed. New York: Springer; 2007. p. 129–44.Google Scholar
  10. 10.
    Piso P, Werner U, Lang H, et al. Proximal versus distal gastric carcinoma—what are the differences? Ann Surg Oncol. 2000;7:520–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Huang Q, Shi J, Sun Q, et al. Clinicopathological characterisation of small (2 cm or less) proximal and distal gastric carcinomas in a Chinese population. Pathology. 2015;47(6):526–32.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Paraf F, Flejou JF, Pignon JP, et al. Surgical pathology of adenocarcinoma arising in Barrett’s esophagus: analysis of 67 cases. Am J Surg Pathol. 1995;19:183–91.CrossRefPubMedGoogle Scholar
  13. 13.
    Nie L, Yao F, Chen TT, Fan XS, Huang Q. Proximal gastric carcinosarcoma with chondrosarcoma differentiation: a case report and review of the literature. Arch Pathol Lab Med. 2017;141:e11.Google Scholar
  14. 14.
    Kobayashi A, Hasebe T, Endo Y, et al. Primary gastric choriocarcinoma: two case reports and a pooled analysis of 53 cases. Gastric Cancer. 2005;8(3):178–85.CrossRefPubMedGoogle Scholar
  15. 15.
    Lauwers GY, Carneiro F, Graham DY, et al. Gastric carcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. Lyon: IARC Press; 2010. p. 48–58.Google Scholar
  16. 16.
    Pinto-de-Sousa J, David L, Reis CA, Gomes R, Silva L, Pimenta A. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch. 2002;440(3):304–10.CrossRefPubMedGoogle Scholar
  17. 17.
    Yasuda K, Adachi Y, Shiraishi N, Maeo S, Kitano S. Papillary adenocarcinoma of the stomach. Gastric Cancer. 2000;3(1):33–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Kang HJ, Kim DH, Jeon TY, et al. Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection. Gastrointest Endosc. 2010;72(3):508–15.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Yu HP, Fang C, Chen L, et al. Worse prognosis in papillary, compared to tubular, early gastric carcinoma. J Cancer. 2017;8(1):117–23.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Huang Q, Fang C, Shi J, et al. Differences in clinicopathology of early gastric carcinoma between proximal and distal location in 438 Chinese patients. Sci Rep. 2015;5:13439.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Murphy G, Pfeiffer R, Camargo MC, Rabkin CS. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009;137(3):824–33.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Shinozaki-Ushiku A, Kunita A, Fukayama M. Update on Epstein-Barr virus and gastric cancer. Int J Oncol. 2015;46(4):1421–34.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Song HJ, Kim KM. Pathology of Epstein-Barr virus-associated gastric carcinoma and its relationship to prognosis. Gut Liver. 2011;5(2):143–8.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Lim H, Lee IS, Lee JH, et al. Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status. Gastric Cancer. 2017;20(5):793–801.  https://doi.org/10.1007/s10120-017-0703-z.CrossRefPubMedGoogle Scholar
  25. 25.
    Yang J, Wang R, Zhang W, et al. Clinicopathological and prognostic characteristics of hepatoid adenocarcinoma of the stomach. Gastroenterol Res Pract. 2014;2014:140587.  https://doi.org/10.1155/2014/140587. CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Lin CY, Yeh HC, Hsu CM, Lin WR, Chiu CT. Clinicopathological features of gastric hepatoid adenocarcinoma. Biomed J. 2015;38(1):65–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Chandan VS, Shah SS, Torbenson MS, Wu TT. Arginase-1 is frequently positive in hepatoid adenocarcinomas. Hum Pathol. 2016;55:11–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Huang Q, Gold JS, Shi J, et al. Pancreatic acinar-like adenocarcinoma of the proximal stomach involving the esophagus. Hum Pathol. 2012;43(6):911–20.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Xu TM, Wang CS, Jia CW, et al. Clinicopathological features of primary gastric neuroendocrine neoplasms: a single-center analysis. J Dig Dis. 2016;17(3):162–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Zhang P, Zhang Y, Zhang C, et al. Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases. Zhonghua Wei Chang Wai Ke Za Zhi. 2016;19(11):1241–6. (in Chinese).PubMedGoogle Scholar
  31. 31.
    Ishida M, Sekine S, Fukagawa T, et al. Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis. Am J Surg Pathol. 2013;37(7):949–59.CrossRefPubMedGoogle Scholar
  32. 32.
    Nie L, Li M, He X, et al. Gastric mixed adenoneuroendocrine carcinoma: correlation of histologic characteristics with prognosis. Ann Diagn Pathol. 2016;25:48–53.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Ishida M, Sekine S, Taniguchi H, et al. Consistent absence of HER2 expression, regardless of HER2 amplification status, in neuroendocrine carcinomas of the stomach. Histopathology. 2014;64(7):1027–31.CrossRefPubMedGoogle Scholar
  34. 34.
    Chen YY, Li AF, Huang KH, et al. Adenosquamous carcinoma of the stomach and review of the literature. Pathol Oncol Res. 2015;21(3):547–51.CrossRefPubMedGoogle Scholar
  35. 35.
    Imai Y, Kawabe T, Takahashi M, et al. A case of primary gastric choriocarcinoma and a review of the Japanese literature. J Gastroenterol. 1994;29(5):642–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Takahashi K, Tsukamoto S, Saito K, Ohkohchi N, Hirayama K. Complete response to multidisciplinary therapy in a patient with primary gastric choriocarcinoma. World J Gastroenterol. 2013;19(31):5187–94.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Baraka BA, Al Kharusi SS, Al Bahrani BJ, Bhathagar G. Primary gastric chorioadenocarcinoma. Oman Med J. 2016;31(5):381–3.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Fukuda S, Fujiwara Y, Wakasa T, et al. Collision tumor of choriocarcinoma and small cell carcinoma of the stomach: a case report. Int J Surg Case Rep. 2017;37:216–20.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Tanimura H, Furuta M. Carcinosarcoma of the stomach. Am J Surg. 1967;113:702–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Ikeda Y, Kosugi S, Nishikura K, et al. Gastric carcinosarcoma presenting as a huge epigastric mass. Gastric Cancer. 2007;10(1):63–8.CrossRefPubMedGoogle Scholar
  41. 41.
    Siegal A, Freund U, Gal R. Carcinosarcoma of the stomach. Histopathology. 1988;13:350–3.CrossRefPubMedGoogle Scholar
  42. 42.
    Selcukbiricik F, Tural D, Senel EF, Dervisoglu S, Serdengectia S. Gastric carcinoma with osteoblastic differentiation. Int J Surg Case Rep. 2012;3(11):516–9.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Tran TB, Hatzaras I, Worhunsky DJ, et al. Gastric remnant cancer: a distinct entity or simply another proximal gastric cancer? J Surg Oncol. 2015;112(8):877–82.CrossRefPubMedGoogle Scholar
  44. 44.
    Irino T, Hiki N, Ohashi M, et al. Characteristics of gastric stump cancer: a single hospital retrospective analysis of 262 patients. Surgery. 2016;159(6):1539–47.CrossRefPubMedGoogle Scholar
  45. 45.
    Tokunaga M, Sano T, Ohyama S, et al. Clinicopathological characteristics and survival difference between gastric stump carcinoma and primary upper third gastric cancer. J Gastrointest Surg. 2013;17(2):313–8.CrossRefPubMedGoogle Scholar
  46. 46.
    Zhou F, Shi J, Fang C, Zou XP, Huang Q. Gastric carcinomas in young (younger than 40 years) Chinese patients: clinicopathology, family history, and post-resection survival. Medicine (Baltimore). 2016;95(9):e2873.CrossRefGoogle Scholar
  47. 47.
    Worthley DL, Phillips KD, Wayte N, et al. Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut. 2012;61:774–9.CrossRefPubMedGoogle Scholar
  48. 48.
    Li J, Woods SL, Healey S, et al. Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Hum Genet. 2016;98(5):830–42.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Kang WM, Yu JC, Ma ZQ, et al. Laparoscopic-endoscopic cooperative surgery for gastric submucosal tumors. World J Gastroenterol. 2013;19(34):5720–6.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol. 2009;33(9):1401–8.CrossRefPubMedGoogle Scholar
  51. 51.
    Abraham SC, Krasinskas AM, Hofstetter WL, Swisher SG, Wu TT. “Seedling” mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction. Am J Surg Pathol. 2007;31(11):1629–35.CrossRefPubMedGoogle Scholar
  52. 52.
    Lee HH, Hur H, Jung H, Jeon HM, Park CH, Song KY. Analysis of 151 consecutive gastric submucosal tumors according to tumor location. J Surg Oncol. 2011;104(1):72–5.CrossRefPubMedGoogle Scholar
  53. 53.
    Agaimy A, Wünsch PH, Hofstaedter F, et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol. 2007;31(1):113–20.CrossRefPubMedGoogle Scholar
  54. 54.
    Aagaard MT, Kristensen IB, Lund O, Hasenkam JM, Kimose HH. Primary malignant non-epithelial tumours of the thoracic oesophagus and cardia in a 25-year surgical material. Scand J Gastroenterol. 1990;25(9):876–82.CrossRefPubMedGoogle Scholar
  55. 55.
    Hsieh CC, Shih CS, Wu YC, et al. Leiomyosarcoma of the gastric cardia and fundus. Zhonghua Yi Xue Za Zhi (Taipei). 1999;62(7):418–24.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Qin Huang
    • 1
    • 2
  1. 1.Pathology and Laboratory MedicineVeterans Affairs Boston Healthcare SystemWest RoxburyUSA
  2. 2.Harvard Medical School and Brigham and Women’s HospitalBostonUSA

Personalised recommendations